CDH1 and neuroendocrine neoplasm: Neuroendocrine tumours have been reported to retain β-catenin expression and E-cadherin expression in the majority of cases, while the subcellular localisation of the E-cadherin/β-catenin complex was altered and associated with lymph node metastasis [34].